Skip to content

Community Servings: Food as Medicine for Diabetes

Community Servings: Food as Medicine for Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02426138
Enrollment
44
Registered
2015-04-24
Start date
2015-04-01
Completion date
2017-07-31
Last updated
2019-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Brief summary

Food insecurity, defined as difficulty accessing food owing to cost, affects 1 in 5 diabetes patients. To address this, the investigators are conducting a pilot randomized controlled trial of medically tailored meal delivery (MTM). The pilot study has two specific aims: Aim 1: To determine the effect of receiving MTM on dietary quality for food insecure diabetes patients with hyperglycemia Aim 2: To determine the feasibility and acceptability of the program as a medical intervention and refine the program as needed for testing in larger studies. This study is a crossover randomized controlled pilot trial, where approximately 50 participants, 25 in each arm, will be randomized to receipt of 12 weeks of MTM, to begin immediately, or waitlist control. After 12 weeks, the groups will crossover, with the waitlist control group now receiving 12 weeks of MTM. At baseline, 12 weeks, and 24 weeks, the participants will complete assessments of their dietary quality (HEI score), psychosocial measures such as diabetes distress and food insecurity, along with measures of body mass index, blood pressure, hemoglobin A1c, and lipids.

Detailed description

a. Historical background The Center for Disease Control and Prevention (CDC) estimates that there are currently 29 million people with diabetes and 86 million people with pre-diabetes in the U.S. One in 10 Americans has diabetes now, and, if current trends continue, 1 in 3 Americans will have diabetes by 2050. This chronic disease significantly impacts both quality of life and rapidly rising national healthcare costs. The estimated cost of diabetes in the U.S. in 2014 was $265 billion with $176 billion in direct medical costs and $89 billion is indirect medical costs (disability, work loss, premature mortality). Medical expenses for people with diabetes are 2.3 times higher than for people without diabetes. Food insecurity, defined as limited access to nutritious food due to cost, has been associated with increased prevalence of diabetes and worse diabetes control. Food insecurity may worsen diabetes by decreasing consumption of fresh fruits and vegetables and increasing consumption of inexpensive, calorie-dense food, and which in turn leads to greater Hemoglobin A1c, an indicator of hyperglycemia, over time. c. Rationale behind the proposed research, and potential benefits to participants and/or society Approximately 20% of diabetes patients report food insecurity, a number that increases to over 25% among those with the worst metabolic control.5 The prevalence of food insecurity is also 20% in the MGH Population we surveyed (data not yet published). Hyperglycemia is particularly responsive to dietary changes,8 yet few interventions have attempted to address food insecurity in diabetes care. Prior studies have examined the impact of the Supplemental Nutrition Assistance Program (SNAP, formerly the Food Stamp Program), but have not found important improvements in diabetes outcomes for participants9. This may be because neighborhood access to produce and other high quality food is low for many SNAP participants, or because making healthy food choices is difficult in resource-constrained environments. Additionally, recent sociological work has shown that expecting low-income women to cook healthy meals for their families induces a significant burden, and the burden of these expectations may drive less healthy food choices. Additionally, while significant time is needed for healthy food preparation, low-income patients often face limited leisure time, and multiple competing demands for both time and financial resources. Alternatively, direct provision of healthy foods was incidentally noted to improve diabetes outcomes in a prior randomized controlled trial, but this study was not conducted with the goal of addressing food insecurity. In this study, we propose to test whether home delivery of freshly prepared meals specifically tailored to the needs of diabetes patients improves their dietary quality. We hypothesize that the delivery of the meals will help them eat more healthily and improve the food security of participants. Secondary outcomes in this pilot study will be weight and metabolic control, along with psychological aspects of diabetes care. Aim 1: To evaluate the effectiveness of receiving Community Servings meals on dietary quality for food insecure diabetes patients with severe hyperglycemia (HbA1c \> 8.0%) H1. Primary outcome. Healthy Eating Index 2010 (HEI) score: We hypothesize that the CS group will demonstrate greater improvements in dietary quality, as assessed by HEI score, at 12 weeks, compared with usual care. The sample size of 50 provides 80% power to detect a 5 point difference between the CS and usual care groups, assuming an 11 point standard deviation and accounting for a 10% drop-out rate. H1b. Secondary exploratory outcomes. Medical outcomes: We hypothesize that compared with usual care, CS group participants will improve HbA1c, blood pressure, weight, and lipids from baseline at the end of the intervention. H1c. Behavioral and psychosocial outcomes: Because meal provision will reduce stress related to procuring healthy meals, and free up household resources that would otherwise be spent on food, we hypothesize that compared with usual care, the CS groups will have greater improvements from baseline in patient-reported outcomes of diabetes distress and material need security. Aim 2: To evaluate the feasibility of providing meals and patient experience with the CS program, particularly focusing on factors that determine acceptability, continuation, and scalability We will use a mixed methods approach using participant structured interviews and surveys to assess engagement and satisfaction with the program, and participant interviews or focus groups to compare responders and non-responders. We will also collect quantitative indicators of feasibility and implementation such as percent of meals delivered and consumed, enrollment and persistence with the program, and logistical issues in order to plan for a future full-scale intervention.

Interventions

OTHERMedically Tailored Meal Delivery (MTM)

Patients will receive delivery of medically tailored meals for 12 weeks

OTHERUsual Care + Choose MyPlate

Patients will receive usual diabetes care + a Choose MyPlate healthy eating brochure for 12 weeks

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* • Diagnosis of type 2 diabetes * Age 18 years or older * HbA1c level \>8.0% * Report food insecurity as indicated by the 2-item USDA Food Security Survey Module13 * Willing to commit to random assignment to either receive CS meals immediately or as a waitlist control * Stable health, with no severe medical comorbidities that might interfere with their ability to participate in the intervention, such as severe psychiatric illness or imminent hospitalization * Be willing to keep a food diary * Be willing to attend and complete a baseline, 12 week, and 24 week assessment at MGH * Be able to understand and communicate effectively in English * Have a primary care physician within the MGH practice based research network * Live in an area where Community Servings can deliver meals * Ability to store and prepare Community Servings meals

Exclusion criteria

* • Must not be pregnant or planning pregnancy in the next year * Currently enrolled in another diabetes study Food allergy that would prohibit consumption of meals * Receiving episodic treatments that may increase blood glucose levels (e.g. prednisone)

Design outcomes

Primary

MeasureTime frameDescription
Healthy Eating Index 2010 ScoreAverage of 3 24-hour food recalls per study period (on and off meals; one in-person visit and 2 over the phone at 4 and 8 weeks into the study)Calculated using data from ASA24 24-hour dietary recall tool Healthy Eating Index 2010 Score Minimum and Maximum range = 0 to 100 Higher scores indicate better diet quality The score is an average of the three-time periods that data was collected

Secondary

MeasureTime frameDescription
Number of Participants With Food InsecurityMeasured at end of On-Meals Period and end of Off-Meals Period for each participantFood insecurity is defined as \> 2 affirmative responses on the 10 adult referenced items USDA Household Food Security Survey Module
Diabetes Distress ScaleMeasured at end of On-Meals Period and end of Off-Meals Period for each participantDiabetes Distress calculated using the Diabetes Distress Scale Minimum and Maximum scores range of the scale is 17-106 For this measure the lower the score the better

Other

MeasureTime frameDescription
Systolic Blood PressureMeasured at end of On-Meals Period and end of Off-Meals Period for each participant using a calibrated sphygmomanometerMeasured using a calibrated sphygmomanometer with appropriate cuff sizes based on arm circumference. Average of 2 readings, first manual and second automated at 1 min intervals following a 5 min period of rest.
Diastolic Blood PressureMeasured at end of On-Meals Period and end of Off-Meals Period for each participant using a calibrated sphygmomanometerMeasured using a calibrated sphygmomanometer with appropriate cuff sizes based on arm circumference. Average of 2 readings, first manual and second automated at 1 min intervals following a 5 min period of rest.
Change From Baseline in Medication AdherenceMeasured at end of On-Meals Period and end of Off-Meals Period for each participantChange from baseline in Medication Adherence Rating Scale (Assessed using medication adherence rating scale) Range is 0-25 The higher the number the better
Number of Participants With Cost Related Medication Under-UseMeasured at end of On-Meals Period and end of Off-Meals Period for each participantCost Related Medication Under-use (Defined as \> 0 affirmative responses to 4-items on cost-related medication under-use from the medication expenditure panel survey)
Number of Participants With Food and Medication Trade-offsMeasured at end of On-Meals Period and end of Off-Meals Period for each participantPrevalence of food and medication trade-offs between groups
Hemoglobin A1cMeasured at end of On-Meals Period and end of Off-Meals Period for each participantThis will be measured using a fasting blood draw at baseline, 12 and 24 weeks
Change From Baseline in Cognitive Burden (Assessed Using Times on the Stroop Task)Measured at end of On-Meals Period and end of Off-Meals Period for each participantThis outcome was planned to be measured but not measured owing to technical difficulties in assessment
Number of Participants With Self-reported HypoglycemiaMeasured at end of On-Meals Period and end of Off-Meals Period for each participantReport of hypoglycemia requiring assistance in last 3 months
TriglyceridesMeasured at end of On-Meals Period and end of Off-Meals Period for each participant by fasting blood drawA fasting blood draw will be used to measure: Triglycerides
HDL CholesterolMeasured at end of On-Meals Period and end of Off-Meals Period for each participant by fasting blood drawA fasting blood draw will be used to measure: HDL Cholesterol
Total CholesterolMeasured at end of On-Meals Period and end of Off-Meals Period for each participant by fasting blood drawA fasting blood draw will be used to measure: Total Cholesterol
Depressive Symptoms (Assessed Using the PHQ-8 Scale)Measured at end of On-Meals Period and end of Off-Meals Period for each participantPatient Health Questionnaire - 8 item version. The score ranges 0-24, The lower score represents less depressive symptoms
LDL CholesterolMeasured at end of On-Meals Period and end of Off-Meals Period for each participantA fasting blood draw will be used to measure: LDL Cholesterol
Body Mass IndexMeasured at end of On-Meals Period and end of Off-Meals Period for each participantBody Mass Index will be measured in light street clothes (without shoes) using a single calibrated scale. Height measured using a stadiometer. Body Mass Index (BMI) is a person's weight in kilograms divided by the square of height in meters. A high BMI can be an indicator of high body fatness.

Countries

United States

Participant flow

Participants by arm

ArmCount
Meal Delivery Then Usual Care + Choose myPlate
During the first intervention period, participants in this arm will receive 12 weeks of medically tailored meal delivery, comprising approximately half of their weekly caloric intake and consisting of foods prepared under the supervision of a registered dietitian to be compatible with a diabetes diet. They will also receive usual diabetes care and a Choose MyPlate healthy eating brochure. Data recorded during or at the end of the first intervention period will comprise the 'on-meal' data for this participants in this arm. Following this, during the second intervention period, they will receive 12 weeks of usual diabetes care + a Choose MyPlate healthy eating brochure, without meal delivery. Data recorded during or at the end of the second intervention period will comprise the 'off-meal' data for participants in this arm.
20
Usual Care + Choose myPlate Then Meal Delivery
During the first intervention period, participants in this arm will receive 12 weeks of usual diabetes care + a Choose MyPlate healthy eating brochure, without meal delivery. Data recorded during or at the end of the first intervention period will comprise the 'off-meal' data for participants in this arm. Following this, during the second intervention period, participants will receive 12 weeks of medically tailored meal delivery, comprising approximately half of their weekly caloric intake and consisting of foods prepared under the supervision of a registered dietitian to be compatible with a diabetes diet. They will also receive usual diabetes care and a Choose MyPlate healthy eating brochure. Data recorded during or at the end of the second intervention period will comprise the 'on-meal' data for this participants in this arm.
22
Total42

Withdrawals & dropouts

PeriodReasonFG000FG001
First Intervention (12 Weeks)Withdrawal by Subject11

Baseline characteristics

CharacteristicMeal Delivery Then Usual Care + Choose myPlateUsual Care + Choose myPlate Then Meal DeliveryTotal
Age, Continuous57.66 years
STANDARD_DEVIATION 12.25
59.21 years
STANDARD_DEVIATION 13.11
58.5 years
STANDARD_DEVIATION 12.6
Healthy Eating Index 2010 Score57.27 units on a scale
STANDARD_DEVIATION 14.65
57.16 units on a scale
STANDARD_DEVIATION 13.49
57.21 units on a scale
STANDARD_DEVIATION 14.04
Race/Ethnicity, Customized
Hispanic
4 Participants3 Participants7 Participants
Race/Ethnicity, Customized
Non-Hispanic Black
5 Participants6 Participants11 Participants
Race/Ethnicity, Customized
Non-Hispanic White
10 Participants13 Participants23 Participants
Race/Ethnicity, Customized
Other
1 Participants0 Participants1 Participants
Region of Enrollment
United States
20 participants22 participants42 participants
Sex: Female, Male
Female
13 Participants16 Participants29 Participants
Sex: Female, Male
Male
7 Participants6 Participants13 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 420 / 42
other
Total, other adverse events
0 / 420 / 42
serious
Total, serious adverse events
0 / 420 / 42

Outcome results

Primary

Healthy Eating Index 2010 Score

Calculated using data from ASA24 24-hour dietary recall tool Healthy Eating Index 2010 Score Minimum and Maximum range = 0 to 100 Higher scores indicate better diet quality The score is an average of the three-time periods that data was collected

Time frame: Average of 3 24-hour food recalls per study period (on and off meals; one in-person visit and 2 over the phone at 4 and 8 weeks into the study)

Population: ITT

ArmMeasureValue (MEAN)Dispersion
On MealsHealthy Eating Index 2010 Score71.30 units on a scaleStandard Deviation 7.49
Off MealsHealthy Eating Index 2010 Score39.89 units on a scaleStandard Deviation 7.8
Secondary

Diabetes Distress Scale

Diabetes Distress calculated using the Diabetes Distress Scale Minimum and Maximum scores range of the scale is 17-106 For this measure the lower the score the better

Time frame: Measured at end of On-Meals Period and end of Off-Meals Period for each participant

Population: ITT

ArmMeasureValue (MEAN)Dispersion
On MealsDiabetes Distress Scale30.94 units on a scaleStandard Deviation 13.77
Off MealsDiabetes Distress Scale30.82 units on a scaleStandard Deviation 10.7
Secondary

Number of Participants With Food Insecurity

Food insecurity is defined as \> 2 affirmative responses on the 10 adult referenced items USDA Household Food Security Survey Module

Time frame: Measured at end of On-Meals Period and end of Off-Meals Period for each participant

Population: ITT

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
On MealsNumber of Participants With Food Insecurity13 Participants
Off MealsNumber of Participants With Food Insecurity24 Participants
Other Pre-specified

Body Mass Index

Body Mass Index will be measured in light street clothes (without shoes) using a single calibrated scale. Height measured using a stadiometer. Body Mass Index (BMI) is a person's weight in kilograms divided by the square of height in meters. A high BMI can be an indicator of high body fatness.

Time frame: Measured at end of On-Meals Period and end of Off-Meals Period for each participant

Population: ITT

ArmMeasureValue (MEAN)Dispersion
On MealsBody Mass Index34.24 kg/m^2Standard Deviation 6.76
Off MealsBody Mass Index34.79 kg/m^2Standard Deviation 6.97
Other Pre-specified

Change From Baseline in Cognitive Burden (Assessed Using Times on the Stroop Task)

This outcome was planned to be measured but not measured owing to technical difficulties in assessment

Time frame: Measured at end of On-Meals Period and end of Off-Meals Period for each participant

Population: This outcome was planned to be measured but not measured owing to technical difficulties in assessment

Other Pre-specified

Change From Baseline in Medication Adherence

Change from baseline in Medication Adherence Rating Scale (Assessed using medication adherence rating scale) Range is 0-25 The higher the number the better

Time frame: Measured at end of On-Meals Period and end of Off-Meals Period for each participant

Population: ITT

ArmMeasureValue (MEAN)Dispersion
On MealsChange From Baseline in Medication Adherence23.19 units on a scaleStandard Deviation 2.86
Off MealsChange From Baseline in Medication Adherence22.28 units on a scaleStandard Deviation 3.21
Other Pre-specified

Depressive Symptoms (Assessed Using the PHQ-8 Scale)

Patient Health Questionnaire - 8 item version. The score ranges 0-24, The lower score represents less depressive symptoms

Time frame: Measured at end of On-Meals Period and end of Off-Meals Period for each participant

Population: ITT

ArmMeasureValue (MEAN)Dispersion
On MealsDepressive Symptoms (Assessed Using the PHQ-8 Scale)6.16 units on a scaleStandard Deviation 5.15
Off MealsDepressive Symptoms (Assessed Using the PHQ-8 Scale)6.13 units on a scaleStandard Deviation 4.96
Other Pre-specified

Diastolic Blood Pressure

Measured using a calibrated sphygmomanometer with appropriate cuff sizes based on arm circumference. Average of 2 readings, first manual and second automated at 1 min intervals following a 5 min period of rest.

Time frame: Measured at end of On-Meals Period and end of Off-Meals Period for each participant using a calibrated sphygmomanometer

Population: ITT

ArmMeasureValue (MEAN)Dispersion
On MealsDiastolic Blood Pressure76.86 mm hgStandard Deviation 8.65
Off MealsDiastolic Blood Pressure78.16 mm hgStandard Deviation 10.11
Other Pre-specified

HDL Cholesterol

A fasting blood draw will be used to measure: HDL Cholesterol

Time frame: Measured at end of On-Meals Period and end of Off-Meals Period for each participant by fasting blood draw

Population: ITT

ArmMeasureValue (MEAN)Dispersion
On MealsHDL Cholesterol45.81 mg/dlStandard Deviation 11.23
Off MealsHDL Cholesterol46.36 mg/dlStandard Deviation 10.2
Other Pre-specified

Hemoglobin A1c

This will be measured using a fasting blood draw at baseline, 12 and 24 weeks

Time frame: Measured at end of On-Meals Period and end of Off-Meals Period for each participant

Population: ITT

ArmMeasureValue (MEAN)Dispersion
On MealsHemoglobin A1c7.99 % of hemoglobinStandard Deviation 1.86
Off MealsHemoglobin A1c8.15 % of hemoglobinStandard Deviation 1.72
Other Pre-specified

LDL Cholesterol

A fasting blood draw will be used to measure: LDL Cholesterol

Time frame: Measured at end of On-Meals Period and end of Off-Meals Period for each participant

Population: ITT

ArmMeasureValue (MEAN)Dispersion
On MealsLDL Cholesterol97.54 mg/dlStandard Deviation 35.67
Off MealsLDL Cholesterol101.43 mg/dlStandard Deviation 43.11
Other Pre-specified

Number of Participants With Cost Related Medication Under-Use

Cost Related Medication Under-use (Defined as \> 0 affirmative responses to 4-items on cost-related medication under-use from the medication expenditure panel survey)

Time frame: Measured at end of On-Meals Period and end of Off-Meals Period for each participant

Population: ITT

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
On MealsNumber of Participants With Cost Related Medication Under-Use7 Participants
Off MealsNumber of Participants With Cost Related Medication Under-Use11 Participants
Other Pre-specified

Number of Participants With Food and Medication Trade-offs

Prevalence of food and medication trade-offs between groups

Time frame: Measured at end of On-Meals Period and end of Off-Meals Period for each participant

Population: ITT

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
On MealsNumber of Participants With Food and Medication Trade-offs9 Participants
Off MealsNumber of Participants With Food and Medication Trade-offs9 Participants
Other Pre-specified

Number of Participants With Self-reported Hypoglycemia

Report of hypoglycemia requiring assistance in last 3 months

Time frame: Measured at end of On-Meals Period and end of Off-Meals Period for each participant

Population: ITT

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
On MealsNumber of Participants With Self-reported Hypoglycemia14 Participants
Off MealsNumber of Participants With Self-reported Hypoglycemia23 Participants
Other Pre-specified

Systolic Blood Pressure

Measured using a calibrated sphygmomanometer with appropriate cuff sizes based on arm circumference. Average of 2 readings, first manual and second automated at 1 min intervals following a 5 min period of rest.

Time frame: Measured at end of On-Meals Period and end of Off-Meals Period for each participant using a calibrated sphygmomanometer

Population: ITT

ArmMeasureValue (MEAN)Dispersion
On MealsSystolic Blood Pressure133.04 mm hgStandard Deviation 17.6
Off MealsSystolic Blood Pressure136.00 mm hgStandard Deviation 18.77
Other Pre-specified

Total Cholesterol

A fasting blood draw will be used to measure: Total Cholesterol

Time frame: Measured at end of On-Meals Period and end of Off-Meals Period for each participant by fasting blood draw

Population: ITT

ArmMeasureValue (MEAN)Dispersion
On MealsTotal Cholesterol182.63 mg/dlStandard Deviation 47.3
Off MealsTotal Cholesterol178.69 mg/dlStandard Deviation 43.82
Other Pre-specified

Triglycerides

A fasting blood draw will be used to measure: Triglycerides

Time frame: Measured at end of On-Meals Period and end of Off-Meals Period for each participant by fasting blood draw

Population: ITT

ArmMeasureValue (MEDIAN)
On MealsTriglycerides142.00 mg/dl
Off MealsTriglycerides127.50 mg/dl

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026